drugset / Trial / NCT01511029
Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)
RandomizedCrossoverDouble-blindTreatment
Summary
To evaluate whether dexpramipexole prolongs the QTc interval when orally administered to healthy volunteers.
Timeline
- Start
- 2012-01
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexpramipexole | Small molecule | 300 mg | Oral |
| Subject | Dexpramipexole | Small molecule | 600 mg | Oral |
| Comparator | Moxifloxacin | Small molecule | 400 mg | Oral |